ABSSSI
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Tebipenem (SPR994) Tissue Penetration in Diabetic Patients With Wound Infections and Healthy Volunteers Via In Vivo Microdialysis (NCT04919954) | Hartford Hospital | 2021-07-01 |
| Vancomycin Versus Ceftaroline in Patients With Infections Caused by MRSA That Are Susceptible to Ceftaroline (NCT01724671) | CPL Associates | 2012-12-01 |
Track ABSSSI automatically
Every clearance here is in the API, with alerts when new ones post.